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The Ca*+-sensitive thin filaments of aorta smooth muscle have been, disassembled into their constituent 
proteins, actin, tropomyosin and a 120-kDa protein. The 120-kDa protein bound to aorta actin-tropo- 
myosin and inhibited its ability to activate myosin MgATPase. This inhibition correlated with the binding 
of one 120-kDa protein molecule per 29 actin monomers. Upon the addition of calmodulin to the actin- 
tropomyosin-120-kDa protein complex, the inhibition was relieved in 10P4 M Ca2+ but not 10e9 M Ca2+. 
The full release of inhibition was not accompanied by a full release of 120-kDa protein binding to actin- 
tropomyosin. A fully active, Ca2+ -sensitive aorta thin filament has thus been reconstituted from just four 
components: actin, tropomyosin, 120-kDa protein and calmodulin. 
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1. INTRODUCTION 2. METHODS 
In smooth muscle the activation of myosin by 
actin, and hence contraction, is controlled by 
changes in the cytoplasmic Ca2+ concentration in 
the range 10e7- lo-’ M [ 11. There is widespread 
agreement that the phosphorylation of the 20-kDa 
light chain of myosin by the Ca*+-calmodulin- 
dependent myosin light chain kinase is a key event 
in this activation [l-3]. However, various studies 
using intact [4,5] and chemically skinned [6,7] 
smooth muscle, and isolated contractile proteins 
[8-121 indicate that some other Ca*+-dependent 
mechanism is involved in the regulation of contrac- 
tile activity. We have previously purified thin 
filaments from aorta smooth muscle which ac- 
tivate skeletal muscle myosin MgATPase in a 
Ca*+-dependent manner [8,9]. We can now 
disassemble these thin filaments and separate their 
three major components: actin, tropomyosin and a 
120-kDa protein. These three components can be 
reconstituted along with calmodulin to give a thin 
filament which activates myosin MgATPase in a 
Ca*+-dependent manner like the native thin 
filaments. 
Our starting material was Ca*+-regulated thin 
filaments from sheep aorta, prepared according to 
our recent procedure [9]. Their main protein com- 
ponents were actin, tropomyosin and the 120-kDa 
protein (see fig.lA). Sheep aorta actin and the 
120-kDa protein were purified from thin filaments 
as follows. The thin filament pellets obtained from 
100-120 g artery were homogenised in 35 ml cold 
0.8 M KCl, 2 gg pepstatin/ml + inhibitor solution 
(2 mM dithiothreitol, 2 pg chymostatin/ml; 2 pg 
leupeptin/inl). The actin was sedimented at 
407000 x g for 90 min leaving the tropomyosin, 
120-kDa protein, and myosin in the supernatant. 
The supernatant was made to 10 mM citric acid- 
NaOH (pH 5.5) from 1 M stock and the pH ad- 
justed with 1 M HCl to pH 2.9-3.0. At this pH, 
the tropomyosin precipitated together with any re- 
maining actin and myosin whilst most of the 
120-kDa protein remained in solution. After cen- 
trifugation (47800 x g for 10 min) the pH of the 
supernatant was adjusted to 7.0 and it was then 
dialysed overnight against 500 ml ATPase buffer 
(60 mM KCl, 5 mM MgC12, 10 mM NaN3, 10 mM 
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Fig. 1. Polyacrylamide (4-30% gradient)/O. 1% 
SDS/40 mM Tris/ZO mM sodium acetate/2 mM EDTA 
(pH 7.4) gel electrophoresis of sheep aorta thin filament 
proteins. Gels were stained with 0.25% Coomassie blue 
and scanned by an LKB Ultrascan densitometer. (i) 
Native thin filament preparation [9], identified bands 
and band area relative to actin are: (1) myosin heavy 
chain, 0.05; (2) 120-kDa protein, 0.10; (3) actin, 1; (4) 
tropomyosin, 0.40. (ii) Purified F-actin. (iii) Purified 
tropomyosin. (iv) Purified 120-kDa protein. 
Tris-Mes, pH 7.0) + inhibitor solution. The 
120-kDa protein was further purified and concen- 
trated by ammonium sulphate fractionation 
(40-50%). The 120-kDa protein was typically ob- 
tained in a yield of 7-12 mg/g thin filament pro- 
tein and with a purity of 70-80% as judged by 
SDS gel electrophoresis (see fig.1). The principal 
impurities were protein bands of 80-l 10 kDa. 
These were probably degraded fragments of the 
120-kDa protein since they were not present in 
native thin filaments and the 120-kDa protein has 
been found to be highly susceptible to proteolytic 
degradation [9]. Aorta tropomyosin and skeletal 
muscle myosin were prepared by standard methods 
[9] and bovine brain calmodulin was purified by 
phenyl-Sepharose affinity chromatography [13]. 
3. RESULTS 
3.1. I20-kDa protein inhibits actin-tropomyosin 
cofactor activity 
The vascular smooth muscle actin-tropomyosin 
complex can activate skeletal muscle myosin 
MgATPase activity at least 50-fold [9]. Low con- 
centrations of the purified 120-kDa protein were 
potent inhibitors of this activation as shown in 
fig.2. A maximum of 95% inhibition was ob- 
served. The 120-kDa protein inhibited actin- 
tropomyosin activation of myosin MgATPase ac- 
tivity under all conditions tested (ionic strength 
0.095-0.165; 25-37°C) and was independent of 
the Ca2+ concentration (range 1O-g-1O-4 M, 
fig.2). In contrast, the 120-kDa protein did not in- 
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Fig.2. Binding of the 120-kDa protein to sheep aorta 
actin tropomyosin at 10m4 M Ca*+ ( l ) and inhibition of 
skeletal myosin/aorta actin-tropomyosin MgATPase 
activity by the 120-kDa protein at 10e9 M Ca*+ (0) and 
10m4 M Ca*+ (0). Conditions: 37”C, 70 mM KCl, 
5 mM MgC12, 10 mM NaNs, 10 mM Tris-Mes (pH 7.0), 
0.1 mM dithiothreitol, 0.5 mg/ml (12,uM) aorta actin, 
0.12 mg/ml aorta tropomyosin and O-O.16 mg/ml 
(1.3 PM) 120-kDa protein. For binding measurements, 
120-kDa protein was covalently labelled with 
iodo[r4C]acetamide [18]. Aorta actin, aorta 
tropomyosin and r4C-labelled 120-kDa protein were 
mixed in a volume of 0.25 ml. Actin-120-kDa protein 
complexes were separated from free 120-kDa protein by 
high-speed sedimentation (1.5 h at 50000 x g) [18]. 
Aliquots were taken for assay of radioactivity before 
(= total 120-kDa protein) and after sedimentation 
(= unbound 120 kDa protein). Difference = bound 
120 kDa protein. ATPase measurements were made with 
the addition of 0.12 mg/ml skeletal muscle myosin. The 
reaction was started by adding MgATP to 2 mM and 
terminated after 10 min by quenching in an equal 
volume of 5% trichloroacetic acid. Phosphate released 
was assayed by the method of Taussky and Schorr [17]. 
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hibit activation by pure smooth muscle actin 
filaments under comparable conditions. 
3.2. The X20-kDa protein binds to actin, 
actin-tropomyosin and calmodulin 
The 120-kDa protein binding to actin and actin- 
tropomyosin was measured by sedimentation of 
the actin-120-kDa protein complex using the 
radioactivity labelled 120-kDa protein (see fig.2). 
When binding was measured over a concentration 
range of 0.01 to 14pM 120-kDa protein (12/M 
actin-tropomyosin) the binding curve was not sim- 
ple. At low concentrations, high affinity binding to 
actin-tropomyosin was observed (K = 2 x 
lo7 M-l, 60 mM KCl, 25’C) saturating at one 
120-kDa molecule bound per 20-30 actins. Further 
weaker binding (K = 3 x lo6 M-l, 60 mM KCl, 
25’C) saturated at around one 120-kDa protein per 
4-7 actins. Comparison of binding and ATPase 
data (fig.2) shows that the inhibitory action of the 
120-kDa protein correlated (correlation coeffi- 
cient = 0.994) with binding of one molecule per 29 
actins. The binding constant for the high affinity 
sites depended on ionic strength @-fold decrease 
between Z = 0.95 and Z = 0.155) but was not very 
temperature-dependent (less than 2-fold decrease 
between 25°C and 37’C). The 120-kDa protein 
also bound to pure smooth muscle actin filaments 
with a similar stoichiometry, but a 4-7-fold reduc- 
tion in affinity compared with actin-tropomyosin. 
The 120-kDa protein bound to bovine brain 
Ca*+-calmodulin coupled to CNBr Sepharose 
with an affinity of about lo6 M-l. This binding 
did not occur in the absence of Ca’+. 
3.3. Inhibition is reversed by C~i-calmodulin 
When the 120-kDa protein was tested with 
skeletal muscle myosin and actin and aorta 
tropomyosin, its inhibition of MgATPase could be 
readily reversed by the addition of Ca2+-cal- 
modulin [20]. To demonstrate a similar effect of 
Ca’+-calmodulin upon the system reconstituted 
from aorta actin, tropomyosin and the 120-kDa 
protein, the assay conditions had to be adjusted to 
favour the hydrophobic interaction of the 120-kDa 
protein with Ca2+ -calmodulin at the expense of its 
interaction with actin-tropomyosin. At 37°C and 
70 mM KCl, the addition of calmodulin to the 
actin-tropomyosin- 120-kDa protein complex pro- 
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Fig.3. Release of inhibition due to 120-kDa protein by 
Ca2+ and brain calmodulin. Conditions as in fig.2; 
0.5 mg/ml (12 PM) aorta actin, 0.12 mg/ml aorta 
tropomyosin, 0.15 mg/ml (1.2 PM) 120-kDa protein, 
O-O.75 mg/ml calmodulin and 0.12 mg/ml skeletal 
muscle myosin (ATPase measurements only). (0) 
MgATPase activity at 10m4 M Ca2+. (0) MgATPase 
activity at 10e9 M Ca2+. ( n ) 120-kDa protein binding at 
low4 M Ca’+. 
no effect in 10v9 M Ca2+ (fig.3). Measurements of 
120-kDa protein binding to actin-tropomyosin 
under the same conditions showed that Ca2+-cal- 
modulin caused a decrease in binding of up to 
40070, when the relief of inhibition was complete 
(fig.3). 
4. DISCUSSION 
Thin filaments of vascular smooth muscle con- 
tain three major protein components: actin, 
tropomyosin and the 120-kDa protein. We isolated 
all these components (fig.1) and found that the 
120-kDa protein is a potent inhibitor of actin- 
tropomyosin cofactor activity (fig.2). With the fur- 
ther addition of Ca’+-calmodulin we reconstituted 
a fully Ca’+-regulated synthetic thin filament 
(fig.3). Thus, 120-kDa protein plays a key role in 
regulation. 
The stoichiometry of the actin-120-kDa protein 
interaction in particular, is worthy of note. 
Ca2+-sensitive native aorta thin filaments contain 
one 120-kDa protein per 28 actins (see fig.1) [9] 
and full inhibition of actin-tropomyosin by pure 
120-kDa protein is correlated with one 120-kDa 
protein bound per 29 actins (see fig.2). This ratio 
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is considerably higher than the 7: 1 molar ratio of 
actin : troponin in striated muscle thin filaments 
[14], the only other documented system of actin- 
based regulation. Investigation of how l%O-kDa 
protein works at these low ratios will be of great 
interest. 
The calmodulin requirement in these reconstitu- 
tion experiments is also of interest. Under the con- 
ditions of our assay (fig.2), the concentration of 
calmodulin required for full relief of inhibition in 
10m4 M Ca2+ is greater than the total tissue content 
of calmodulin in bovine aorta (0.15 mg/g) [ 191. 
Furthermore, native aorta thin filaments have a 
low complement of calmodulin-like protein and 
yet are Ca2+ -sensitive [8,9]. There are two possible 
ways of accounting for this discrepancy. First, it is 
apparent that the calmodulin requirement of the 
reconstituted regulatory system is highly deeen- 
dent upon the conditions (temperature, ionic 
strength) used for measurement. Second, it is 
possible that the native thin filaments contain a 
different Ca2+-binding protein which is more po- 
tent than the brain calmodulin used in this system. 
Our results suggest a hypothesis for the regula- 
tion of smooth muscle thin filaments by Ca’+. 
Vascular smooth muscle thin filaments have 4 
components: actin, tropomyosin, 120-kDa protein 
and a calcium-binding protein. The actin, 
tropomyosin and 120-kDa protein are present in 
approximate molar ratios of 1: l/7 : l/28. At 
resting levels of Ca’+, the actin-tropomyosin is 
unable to activate myosin due to the inhibitory ef- 
fect of the bound 120-kDa protein. At high Ca2+ 
concentrations, a Ca2+ -calmodulin-binding pro- 
tein complex interacts with the 120-kDa protein, 
thereby altering its binding to actin-tropomyosin 
and releasing its inhibitory effect upon the activa- 
tion of myosin. 
The regulatory properties of our 120-kDa pro- 
tein are very similar to those reported for the 
calmodulin-binding protein, caldesmon [ 10,231. 
We have found that the 120-kDa protein and 
caldesmon are indistinguishable as judged by the 
SDS-gel electrophoresis [22], the cleavage pattern 
using V8 protease and antibody cross reaction (in 
preparation). Our hypothesis for regulation by the 
120-kDa protein differs from that proposed by 
Sobue et al. [lo], namely, a mutually exclusive 
binding of caldesmon, either to Ca2+-calmodulin 
or actin-tropomyosin (‘flip-flop’ mechanism), 
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whilst we find a complete neutralisation of the in- 
hibitory effect of the 120-kDa protein by 
Ca2+-calmodulin associated with only partial 
release of the 120-kDa protein from actin- 
tropomyosin (fig.3). However, the results of Ngai 
et al. [ 151 with gizzard caldesmon are in agreement 
with our observations (fig.3). 
Caldesmon promotes bundling of actin fila- 
ments [23,24] and so does the 120-kDa protein. (C. 
Moody, unpublished). We do not think bundling is 
responsible for the inhibitory effect of the 120-kDa 
protein since it requires much larger 120-kDa pro- 
tein : actin ratios than inhibition and unlike inhibi- 
tion, occurs equally well in the presence or absence 
of tropomyosin (C. Moody, unpublished). 
The observations reported here add further 
weight to the contention that the contractile activi- 
ty of vascular smooth muscle is controlled by 
separate Ca2+-dependent mechanisms associated 
with both the myosin and actin filaments 
[1,8-10,161. 
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